Capstone Investment Advisors LLC Boosts Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Capstone Investment Advisors LLC raised its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 14.1% during the third quarter, Holdings Channel reports. The fund owned 1,438 shares of the biotechnology company’s stock after acquiring an additional 178 shares during the period. Capstone Investment Advisors LLC’s holdings in Axon Enterprise were worth $575,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also bought and sold shares of AXON. Blue Trust Inc. raised its stake in Axon Enterprise by 987.5% during the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after acquiring an additional 79 shares during the period. Quent Capital LLC raised its position in shares of Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after purchasing an additional 75 shares during the period. Brooklyn Investment Group purchased a new position in shares of Axon Enterprise during the 3rd quarter valued at $41,000. Asset Dedication LLC bought a new position in Axon Enterprise in the 2nd quarter worth $47,000. Finally, Planning Capital Management Corp increased its stake in Axon Enterprise by 83.3% in the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after buying an additional 55 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $646.96 on Friday. Axon Enterprise, Inc. has a 12-month low of $224.28 and a 12-month high of $652.22. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The firm has a 50-day moving average price of $483.18 and a 200-day moving average price of $376.61. The firm has a market capitalization of $49.33 billion, a PE ratio of 167.17, a price-to-earnings-growth ratio of 13.97 and a beta of 0.94.

Wall Street Analyst Weigh In

AXON has been the subject of a number of recent analyst reports. Needham & Company LLC upped their price objective on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. The Goldman Sachs Group upped their price target on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Barclays lifted their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. Craig Hallum lifted their target price on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. Finally, JMP Securities boosted their target price on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $427.83.

Insiders Place Their Bets

In related news, Director Jeri Williams sold 110 shares of Axon Enterprise stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $400.00, for a total transaction of $44,000.00. Following the completion of the sale, the director now owns 1,934 shares in the company, valued at $773,600. This trade represents a 5.38 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Patrick W. Smith sold 75,000 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $356.53, for a total transaction of $26,739,750.00. Following the completion of the transaction, the chief executive officer now owns 2,970,366 shares in the company, valued at $1,059,024,589.98. This represents a 2.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 210,256 shares of company stock valued at $87,783,120 over the last 90 days. Insiders own 6.10% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.